NCT03714945

Brief Summary

Pilot study on the association between allergic rhinitis and cognitive ability in 174 children aged 11-14 within the same year group at school in which 140 Allergic Rhinitis subjects and 34 non-Allergic Rhinitis subjects. Primary outcome measures include cognitive tests (Trait Making Test, Digit Span Test, Stroop Test, Chinese Auditory Verbal Learning Test, Verbal Fluency Test), so as to assess the cognitive ability of allergic rhinitis patients before and after treatment compared to a control group. Rhinitis Symptom Utility Index (RSUI) of patients will be the secondary outcome measured through questionnaires. Positive skin prick test and endoscopy examination (taking place in Prince of Wales hospital) will be required before the diagnosis of allergic rhinitis. The data will be analysed by the Multilevel models.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
174

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2017

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 22, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 22, 2018

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2020

Completed
Last Updated

June 26, 2019

Status Verified

June 1, 2019

Enrollment Period

3.1 years

First QC Date

September 22, 2018

Last Update Submit

June 25, 2019

Conditions

Keywords

Allergic RhinitisChildrenCognitive Ability

Outcome Measures

Primary Outcomes (1)

  • Trait Making Test (TMT)

    It tests how fast and accurate the subjects can connect all numbered dots and alphabets in specified instruction. Shorted completion time with accurate compliance to instructions denotes higher score.

    8 weeks

Secondary Outcomes (5)

  • Rhinitis Symptom Utility Index (RSUI)

    8 weeks

  • Stroop Test (Chinese Translated Victoria Version)

    8 weeks

  • Digit Span Test (DST)

    8 weeks

  • Chinese Auditory Verbal Learning Test

    8 weeks

  • Verbal Fluency Test

    8 weeks

Study Arms (2)

Case Group with Allergic Rhinitis

\- Inclusion Criteria 1. Both genders of 11-14 years, diagnosed with allergic rhinitis on basis of screening instruments, medical history, clinical assessment (by general ORL examination including nasal endoscopy) 2. Chinese in ethnicity 3. Positive skin prick test with wheal diameter \>= 3mm 4. Ability to understand the nature, scope, and possible consequences of the study 5. Capability and willingness to comply with the requirements of the protocol

Other: No intervention

Control Group without Allergic Rhinitis

\- Inclusion Criteria 1. Both genders of 11-14 years 2. Chinese in ethnicity 3. Subjects who have not been diagnosed with a long term medical or psychiatric problem 4. Subjects who are not currently undergoing any long term medical treatment.

Other: No intervention

Interventions

No intervention is required as this study is observational.

Case Group with Allergic RhinitisControl Group without Allergic Rhinitis

Eligibility Criteria

Age11 Years - 14 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Students aged 11 to 14 currently studying Form 1 and 2 currently studying in secondary schools in Hong Kong will be recruited directly through invitation. Recruitment will include patients suffering from untreated allergic rhinitis in additional to healthy individuals to serve as a control group. Patients suffering from allergic rhinitis will be classified according to ARIA guidelines into mild/moderate/severe, and duration into intermittent/persistent. Patients suffering from rhinitis due to non-allergic origins or those associated with nasal polyposis or sinusitis will be excluded. Patients are going to complete the Rhinitis Symptom Utility Index (RSUI) questionnaire for assessing pre and post symptoms.

You may qualify if:

  • Both genders of 11-14 years
  • Chinese in ethnicity
  • Subjects who have not been diagnosed with a long term medical or psychiatric problem
  • Subjects who are not currently undergoing any long term medical treatment.
  • Both genders of 11-14 years, diagnosed with allergic rhinitis on basis of screening instruments, medical history, clinical assessment (by general ORL examination including nasal endoscopy)
  • Chinese in ethnicity
  • Positive skin prick test with wheal diameter \>= 3mm
  • Ability to understand the nature, scope, and possible consequences of the study
  • Capability and willingness to comply with the requirements of the protocol

You may not qualify if:

  • Subjects with co-existing nasal conditions other than AR, which may affect nasal pathology (nasal polyposis, sinusitis, severe deviations of nasal septum, tumours of the nasal cavity, acute/chronic rhinosinusitis or any underlying pathology that might affect nasal breathing or nocturnal sleep)
  • Subjects with prior nasal surgery (e.g. nasal cavity, sinuses)
  • Subjects with known brain disorders, prior brain surgery or history of stroke
  • Subjects diagnosed with learning disability, autism or attention deficit hyperactivity disorder (ADHD)
  • Subjects with history of known sleep disorder, central or obstructive sleep apnea, narcolepsy, insomnia, patients requiring regular sleep medication and those hypersensitive to applied topical nasal steroids
  • Subjects who have taken topical nasal steroids, oral anti-histamines or medications affecting nasal symptoms 30 days prior to commencement of study
  • Subjects with hypersensitivity reactions towards topical nasal steroids or oral anti-histamines
  • Subjects previously diagnosed with any psychiatric disorders
  • Subjects who suffered from a respiratory tract infection within the past 30 days
  • Subjects who have clinically major cardiovascular, respiratory, hepatic, neurological, endocrine, immunological or other major systemic disease(s)
  • Subjects who are undergoing a long-term medical treatment plan

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Otorhinolaryngology, Head and Neck Surgery

Hong Kong, 00000, Hong Kong

RECRUITING

Related Publications (19)

  • New Publication by HKU Paediatricians : 'Allergic Rhinitis - The Paediatric Disease You Must Learn' - All News - Media - HKU. (n.d.). Retrieved October 10, 2017, from http://www.hku.hk/press/news_detail_6527.html

    BACKGROUND
  • Aetiology of allergic rhinitis in Hong Kong. (2015, March 19). Retrieved October 10, 2017, from http://www.sciencedirect.com/science/article/pii/S1323893015315343

    BACKGROUND
  • Vuurman EF, Vuurman LL, Lutgens I, Kremer B. Allergic rhinitis is a risk factor for traffic safety. Allergy. 2014 Jul;69(7):906-12. doi: 10.1111/all.12418. Epub 2014 May 9.

    PMID: 24815889BACKGROUND
  • Allergic rhinitis: impact, diagnosis, treatment and management. (2016, August 09). Retrieved October 10, 2017, from http://www.pharmaceutical-journal.com/research/review-article/allergic-rhinitis-impact-diagnosis-treatment-and-management/20201509.article

    BACKGROUND
  • Walker S, Khan-Wasti S, Fletcher M, Cullinan P, Harris J, Sheikh A. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol. 2007 Aug;120(2):381-7. doi: 10.1016/j.jaci.2007.03.034. Epub 2007 Jun 8.

    PMID: 17560637BACKGROUND
  • Jauregui I, Mullol J, Davila I, Ferrer M, Bartra J, del Cuvillo A, Montoro J, Sastre J, Valero A. Allergic rhinitis and school performance. J Investig Allergol Clin Immunol. 2009;19 Suppl 1:32-9.

    PMID: 19476052BACKGROUND
  • Kim DK, Rhee CS, Han DH, Won TB, Kim DY, Kim JW. Treatment of allergic rhinitis is associated with improved attention performance in children: the Allergic Rhinitis Cohort Study for Kids (ARCO-Kids). PLoS One. 2014 Oct 17;9(10):e109145. doi: 10.1371/journal.pone.0109145. eCollection 2014.

    PMID: 25330316BACKGROUND
  • Lo PS, Tong MC, Revicki DA, Lee CC, Woo JK, Lam HC, van Hasselt CA. Rhinitis Symptom Utility Index (RSUI) in Chinese subjects: a multiattribute patient-preference approach. Qual Life Res. 2006 Jun;15(5):877-87. doi: 10.1007/s11136-005-4828-x.

    PMID: 16721647BACKGROUND
  • Lee T, Yuen K, Chan C. Normative data for neuropsychological measures of fluency, attention, and memory measures for Hong Kong Chinese. J Clin Exp Neuropsychol. 2002 Aug;24(5):615-32. doi: 10.1076/jcen.24.5.615.1001.

    PMID: 12187445BACKGROUND
  • Hitch JG, McAuley E. Working memory in children with specific arithmetical learning difficulties. Br J Psychol. 1991 Aug;82 ( Pt 3):375-86. doi: 10.1111/j.2044-8295.1991.tb02406.x.

    PMID: 1954527BACKGROUND
  • Kremer B, den Hartog HM, Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy. 2002 Sep;32(9):1310-5. doi: 10.1046/j.1365-2745.2002.01483.x.

    PMID: 12220469BACKGROUND
  • Den Hartog HM, Derix MM, Van Bemmel AL, Kremer B, Jolles J. Cognitive functioning in young and middle-aged unmedicated out-patients with major depression: testing the effort and cognitive speed hypotheses. Psychol Med. 2003 Nov;33(8):1443-51. doi: 10.1017/s003329170300833x.

    PMID: 14672253BACKGROUND
  • Pendleton MG, Heaton RK, Lehman RA, Hulihan D. Diagnostic utility of the Thurstone Word Fluency Test in neuropsychological evaluations. J Clin Neuropsychol. 1982 Dec;4(4):307-17. doi: 10.1080/01688638208401139.

    PMID: 7174838BACKGROUND
  • Ardila A, Pineda D, Rosselli M. Correlation between intelligence test scores and executive function measures. Arch Clin Neuropsychol. 2000 Jan;15(1):31-6.

    PMID: 14590565BACKGROUND
  • Norrman G, Falth-Magnusson K. Adverse reactions to skin prick testing in children - prevalence and possible risk factors. Pediatr Allergy Immunol. 2009 May;20(3):273-8. doi: 10.1111/j.1399-3038.2008.00761.x. Epub 2009 Feb 10.

    PMID: 19220772BACKGROUND
  • International Study of Asthma and Allergies in Childhood Phase II Modules. (1998, May). Retrieved October 10, 2017, from International Study of Asthma and Allergies in Childhood Phase II Modules

    BACKGROUND
  • Downie SR, Andersson M, Rimmer J, Leuppi JD, Xuan W, Akerlund A, Peat JK, Salome CM. Symptoms of persistent allergic rhinitis during a full calendar year in house dust mite-sensitive subjects. Allergy. 2004 Apr;59(4):406-14. doi: 10.1111/j.1398-9995.2003.00420.x.

    PMID: 15005764BACKGROUND
  • Adachi, Y., MD, PHD, Yoshida, K., MD, & Itazawa, T., MD. (n.d.). Relationship Between ARIA and ISAAC Questionnaires Regarding to the Classification and Severity of Rhinitis in School Children [Abstract]. Journal of Allergy and Clinical Immunology, 131(2), AB113. Retrieved October 10, 2017, from http://www.jacionline.org/article/S0091-6749(12)03075-8/pdf

    BACKGROUND
  • Goldstein H 1995 Multilevel statistical models. In: Goldstein H, ed. Kendalls library of statistics 3. London: Edward Arnold; 87-94

    BACKGROUND

MeSH Terms

Conditions

Rhinitis, Allergic

Condition Hierarchy (Ancestors)

RhinitisNose DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityOtorhinolaryngologic DiseasesHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Michael Chi Fai CF Tong, MD, MBChB

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Calvin Pok Hong PH LAM, MSSc,MA,BSSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chairman

Study Record Dates

First Submitted

September 22, 2018

First Posted

October 22, 2018

Study Start

December 1, 2017

Primary Completion

December 31, 2020

Study Completion

December 31, 2020

Last Updated

June 26, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share

No plan to make individual participant data (IPD) available to other researchers.

Locations